Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Diana Brainard Insider Profile
4 Followers
Diana Brainard, CEO, Director at AlloVir, holds 723.36K shares in AlloVir (Ticker: ALVR), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of AlloVir on Nov 20, 2024 for an estimated value of 4.70K.
Profitable Transactions
26 out of 28 Profitable Transactions
Average Return
+35.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Diana Brainard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Diana Brainard
Diana Brainard's Trading History
AlloVir
Nov 20, 2024
CEO, Director
Informative Sell
4.70K
$397.85K
Nektar Therapeutics
Sep 20, 2022
Director
Uninformative Buy
―
$31.13K
List of latest transactions for each holding click on a transaction to see Diana Brainard's performance on stock
You May Also Like
Diana Brainard insider profile FAQ
What is the percentage of profitable transactions made by Diana Brainard?
The percentage of profitable transactions made by Diana Brainard is 93%.
What is the average return per transaction made by Diana Brainard?
The average return per transaction made by Diana Brainard is 35.00%.
What stocks does Diana Brainard hold?
Diana Brainard holds: ALVR, NKTR stocks.
What was Diana Brainard’s latest transaction?
Diana Brainard latest transaction was an Informative Sell of $4.70K.
What was Diana Brainard's most profitable transaction?
Diana Brainard’s most profitable transaction was an Informative Sell of ALVR stock on May 19, 2023. The return on the trade was 81.50%.
What is Diana Brainard's role in AlloVir?
Diana Brainard's role in AlloVir is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.